Tag
$GWPH
- US Senate bill would finally allow CBD in food and drinks
- Hexo to enter Europe with $265M Zenabis acquisition
- Jazz Pharma to buy CBD drugmaker GW Pharma for US$7.2B
- Canopy's GW Pharma lawsuit could be trouble for US extractors
- GW Pharma shares soar 21% on rising revenues
- FDA's new draft guidelines could speed up CBD drug approvals
- U.K. reduces wait times for patients accessing cannabis-based medicines
- GW Pharma asks FDA to approve Epidiolex to treat a third epileptic disorder
- US House introduces bill to allow sale of CBD‑infused food and drink
- Industry experts say more executive diversity will improve weed's bottom line
- Aurora's CBD oil approved as Irish medical cannabis product
- U.K. approves 2 cannabis-based medicines
- GW Pharmaceuticals' Cannabis-Based Epilepsy Drug Gets EU Approval
- GW Pharma Doubles Sales on Strong Uptake of CBD Drug Epidiolex
- U.S. FDA Says it is “Expediting” the CBD Regulation Process
- Global Cannabis Sales Will Nearly Triple to US$40.6 Billion by 2024: Report
- Is Lab‑Made Marijuana the Future of the Industry?
- 5 Stocks That Will Benefit from Hemp Legalization in the U.S.